Budesonide is more effective than mesalamine or placebo in short-term treatment of collagenous colitis

Gastroenterology

Volumn 146, Issue 5, 2014, Pages

  Miehlke, Stephan ^a   Madisch, Ahmed ^b   Kupcinskas, Limas ^c   Petrauskas, Dalius ^c   Böhm, Günter ^d   Marks, Hans Joachim ^e   Neumeyer, Michael ^f   Nathan, Torben ^g   Fernández Bañares, Fernando ^h   Greinwald, Roland ⁱ   Mohrbacher, Ralf ⁱ   Vieth, Michael ^j   Bonderup, Ole K ^k  

^a Centre for Digestive Diseases Eppendorf   (Germany)

^b Hospital Siloah   (Germany)

^c LITHUANIAN UNIVERSITY OF HEALTH SCIENCES   (Lithuania)

^d Private Practice   (Germany)

^e Private Practice   (Germany)

^f Private Neurological Practice   (Germany)

^g LILLEBAELT HOSPITAL   (Denmark)

^h Hospital Universitario Mutua Terrassa   (Spain)

ⁱ Silkeborg Hospital ^*  (Germany)

^j INSTITUTE OF PATHOLOGY   (Germany)

^k SILKEBORG REGIONAL HOSPITAL   (Denmark)

more..

Author keywords

Clinical Trial; Drug; Keywords; Microscopic Colitis; Therapy

Indexed keywords

BUDENOFALK; BUDESONIDE; LANSOPRAZOLE; MESALAZINE;

ABDOMINAL PAIN; ADULT; ARTICLE; BODY MASS; BRONCHITIS; COLLAGENOUS COLITIS; COLON BIOPSY; COLONOSCOPY; COMPARATIVE EFFECTIVENESS; CONSTIPATION; CONTROLLED STUDY; COUGHING; DEHYDRATION; DIARRHEA; DISEASE DURATION; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG FEVER; DRUG INDUCED HEADACHE; DYSPEPSIA; FEMALE; FLATULENCE; HISTOLOGY; HUMAN; INNER EAR DISEASE; MAJOR CLINICAL STUDY; MALE; MUSCLE SPASM; NECK PAIN; OROPHARYNX PAIN; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RELAPSE; REMISSION; RHINOPHARYNGITIS; SHORT COURSE THERAPY; SMOKING HABIT; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT; VERTIGO; VOMITING;

CLINICAL TRIAL; DRUG; MICROSCOPIC COLITIS; THERAPY;

ADMINISTRATION, ORAL; ADULT; AGED; ANTI-INFLAMMATORY AGENTS; BUDESONIDE; CAPSULES; COLITIS, COLLAGENOUS; DEFECATION; DELAYED-ACTION PREPARATIONS; DOUBLE-BLIND METHOD; EUROPE; FEMALE; GASTROINTESTINAL AGENTS; HUMANS; MALE; MESALAMINE; MIDDLE AGED; REMISSION INDUCTION; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84899006648     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2014.01.019     Document Type: Article

References (48)

1. D.S. Pardi, and C.P. Kelly Microscopic colitis Gastroenterology 140 2011 1155 1165
2. C. Bjørnbak, P.J.H. Engel, and P.L. Nielsen et al. Microscopic colitis: clinical findings, topography and persistence of histopathological subgroups Aliment Pharmacol Ther 34 2011 1225 1234
3. A. Madisch, P. Heymer, and C. Voss et al. Oral budesonide therapy improves quality of life in patients with collagenous colitis Int J Colorectal Dis 20 2005 312 316
4. H. Hjortswang, C. Tysk, and J. Bohr et al. Health related quality of life is impaired in active collagenous colitis Dig Liv Dis 43 2011 102 109
5. M. Olesen, S. Eriksson, and J. Bohr et al. Microscopic colitis: a common diarrhoeal disease. An epidemiological study in Orebro, Sweden, 1993-1998 Gut 53 2004 346 350
6. D.S. Pardi, E.V. Loftus Jr., and T.C. Smyrk et al. The epidemiology of microscopic colitis: a population based study in Olmsted County, Minnesota Gut 56 2007 504 508
7. M. Stewart, C.N. Andrews, and S. Urbanski et al. The association of coeliac disease and microscopic colitis: a large population-based study Aliment Pharmacol Ther 33 2011 1340 1349
8. F. Fernandez-Banares, A. Salas, and M. Esteve et al. Evolution of the incidence of collagenous colitis and lymphocytic colitis in Terrassa, Spain: a population-based study Inflamm Bowel Dis 17 2011 1015 1020
9. O.H. Nielsen, B. Vainer, and O.B. Schaffalitzky de Muckadell Microscopic colitis: a missed diagnosis? Lancet 364 2004 2055 2057
10. D. Limsui, D.S. Pardi, and M. Camilleri et al. Symptomatic overlap between irritable bowel syndrome and microscopic colitis Inflamm Bowel Dis 13 2007 175 181
11. F. Baert, A. Schmit, and G. D'Haens et al. Budesonide in collagenous colitis: a double-blind placebo-controlled trial with histologic follow-up Gastroenterology 122 2002 20 25
12. S. Miehlke, P. Heymer, and B. Bethke et al. Budesonide treatment for collagenous colitis: a randomized, double-blind, placebo-controlled, multicenter trial Gastroenterology 123 2002 978 984
13. O.K. Bonderup, J.B. Hansen, and L. Birket-Smith et al. Budesonide treatment of collagenous colitis: a randomised, double-blind, placebo controlled trial with morphometric analysis Gut 52 2003 248 251
14. J. Bohr, C. Tysk, and S. Eriksson et al. Collagenous colitis: a retrospective study of clinical presentation and treatment in 163 patients Gut 39 1996 846 851
15. D.S. Pardi, V.R. Ramnath, and E.V. Loftus et al. Lymphocytic colitis: clinical features, treatment, and outcomes Am J Gastroenterol 97 2002 2829 2833
16. F. Fernandez-Banares, A. Salas, and M. Esteve et al. Collagenous and lymphocytic colitis. Evaluation of clinical and histological features, response to treatment, and long-term follow-up Am J Gastroenterol 98 2003 340 347
17. C. Calabrese, A. Fabbri, and A. Areni et al. Mesalazine with or without cholestyramine in the treatment of microscopic colitis: randomized controlled trial J Gastroenterol Hepatol 22 2007 809 814
18. H. Hjortswang, C. Tysk, and J. Bohr et al. Defining clinical criteria for clinical remission and disease activity in collagenous colitis Inflamm Bowel Dis 15 2009 1875 1881
19. N. Chande, J.W.D. McDonald, and J.K. MacDonald Interventions for treating collagenous colitis Cochrane Database of Syst Rev 16 2008 CD003575
20. N. Chande, J.K. MacDonald, and J.W. McDonald Interventions for treating microscopic colitis: a Cochrane Inflammatory Bowel Disease and Functional Bowel Disorders Review Group systematic review of randomized trials Am J Gastroenterol 104 2009 235 241
21. M.J. Stewart, C.H. Seow, and M.A. Storr Prednisolone and budesonide for short- and long-term treatment of microscopic colitis: systematic review and meta-analysis Clin Gastroenterol Hepatol 9 2011 881 890
22. C.H. Seow, E.I. Benchimol, and A.M. Griffiths et al. Budesonide for induction of remission in Crohn's disease Cochrane Database Syst Rev 16 2008 CD000296
23. F.A. Offner, R.V. Jao, and K.J. Lewin et al. Collagenous colitis: a study of the distribution of morphological abnormalities and their histological detection Hum Pathol 30 1999 451 457
24. H.A. Carpenter, W.J. Tremaine, and K.P. Batts et al. Sequential histologic evaluations in collagenous colitis. Correlations with disease behavior and sampling strategy Dig Dis Sci 37 1992 1903 1909
25. M. Tanaka, G. Mazzoleni, and R.H. Riddell Distribution of collagenous colitis: utility of flexible sigmoidoscopy Gut 33 1992 65 70
26. H. Sapp, S. Ithamukkala, and T.P. Brien et al. The terminal ileum is affected in patients with lymphocytic or collagenous colitis Am J Surg Pathol 26 2002 1484 1492
27. V. Padmanabhan, P.W. Callas, and S.C. Li et al. Histopathological features of the terminal ileum in lymphocytic and collagenous colitis: a study of 32 cases and review of literature Mod Pathol 16 2003 115 119
28. V. Gross, I. Bunganic, and E.A. Belousova et al. 3g mesalazine granules are superior to 9mg budesonide for achieving remission in active ulcerative colitis: a double-blind, double-dummy, randomised trial J Crohns Colitis 5 2011 129 138
29. K.A. Ung, R. Gillberg, and A. Kilander et al. Role of bile acids and bile acid binding agents in patients with collagenous colitis Gut 46 2000 170 175
30. A. Bajor, A. Kilander, and C. Gälman et al. Budesonide treatment is associated with increased bile acid absorption in collagenous colitis Aliment Pharmacol Ther 24 2006 1643 1649
31. K.W. Ecker, A. Stallmach, and G. Seitz et al. Oral budesonide significantly improves water absorption in patients with ileostomy for Crohn disease Scand J Gastroenterol 38 2003 288 293
32. K.W. Ecker, A. Stallmach, and J. Löffler et al. Long-term treatment of high intestinal output syndrome with budesonide in patients with Crohn's disease and ileostomy Dis Colon Rectum 48 2005 237 242
33. B.H.M. Lenfers, T.M. Loeffler, and C.M. Droege et al. Substantial activity of budesonide in patients with irinotecan (CPT-1). and 5-fluorouracil induced diarrhea and failure of loperamide treatment Ann Oncol 10 1999 1251 1253
34. S. Miehlke, A. Madisch, and D. Karimi et al. Budesonide is effective in treating lymphocytic colitis: a randomized double-blind placebo-controlled study Gastroenterology 136 2009 2092 2100
35. D.S. Pardi, E.V. Loftus Jr., and W.J. Tremaine et al. A randomized double-blind, placebo controlled trial of budesonide for the treatment of active lymphocytic colitis Gastroenterology 136 Suppl 1 2009 A-519 A-520 T 1193
36. S. Miehlke, A. Madisch, and B. Bethke et al. Oral budesonide for maintenance treatment of collagenous colitis: a randomized, double-blind, placebo-controlled trial Gastroenterology 135 2008 1510 1516
37. O.K. Bonderup, J.B. Hansen, and P.S. Teglbjaerg et al. Long-term budesonide treatment of collagenous colitis: a randomised, double-blind, placebo-controlled trial Gut 58 2009 68 72
38. N.M. Gentile, A.A. Abdalla, and S. Khanna et al. Outcomes of patients with microscopic colitis treated with corticosteroids: a population-based study Am J Gastroenterol 108 2013 256 259
39. A. Münch, D. Aust, and J. Bohr et al. Microscopic colitis: current status, present and future challenges: statements of the European Microscopic Colitis Group J Crohns Colitis 6 2012 932 945
40. H.W. Möllmann, G. Hochhaus, and A. Tromm et al. Pharmacokinetics and pharmacodynamics of budesonide-pH-modified release capsules H.W. Möllmann, B. May, International Falk Workshop 73B: glucocorticoid therapy in chronic inflammatory bowel disease - from basic principles to rational therapy 1996 Kluwer Academic Publishers Dordrecht, Boston, London 107 120
41. M. Ufer, K. Dilger, and L. Leschhorn et al. Influence of CYP3A4, CYP3A5, and ABCB1 genotype and expression on budesonide pharmacokinetics: a possible role of intestinal CYP3A4 expression Clin Pharmacol Ther 84 2008 43 46
42. S. Edsbacker, and T. Andersson Pharmacokinetics of budesonide (Entocort EC) capsules for Crohn's disease Clin Pharmacokinet 43 2004 803 821
43. A. Nicholls, R. Harris-Collazo, and M. Huang et al. Bioavailability profile of Uceris MMX extended-release tablets compared with Entocort EC capsules in healthy volunteers J Int Med Res 41 2013 386 394
44. J. Silverman, and A. Otley Budesonide in the treatment of inflammatory bowel disease Expert Rev Clin Immunol 7 2011 419 428
45. L. Oliveira, and R.D. Cohen Maintaining remission in ulcerative colitis - role of once daily extended-release mesalamine Drug Des Dev Ther 5 2011 111 116
46. G. Lawlor, A. Ahmed, and A.C. Moss Once-daily mesalamine granules for ulcerative colitis Expert Rev Clin Immunol 6 2010 521 526
47. I. Sonu, M.V. Lin, and W. Blonski et al. Clinical pharmacology of 5-ASA compounds in inflammatory bowel disease Gastroenterol Clin North Am 39 2010 559 599
48. W.J. Sandborn Oral 5-ASA therapy in ulcerative colitis: what are the implications of the new formulations? J Clin Gastroenterol 42 2008 338 344